Gilead Sciences Inc earnings per share and revenue
On 30 de out. de 2025, GILD reported earnings of 2.47 USD per share (EPS) for Q3 25, beating the estimate of 2.17 USD, resulting in a 13.68% surprise. Revenue reached 7.77 bilhão, compared to an expected 7.60 bilhão, with a 2.29% difference. The market reacted with a +1.14% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analistas forecast an EPS of 1.89 USD, with revenue projected to reach 7.81 bilhão USD, implying an diminuir of -23.48% EPS, and aumentar of 0.51% in Revenue from the last quarter.
FAQ
What were Gilead Sciences Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Gilead Sciences Inc reported EPS of $2.47, beating estimates by 13.68%, and revenue of $7.77B, 2.29% above expectations.
How did the market react to Gilead Sciences Inc's Q3 2025 earnings?
The stock price moved up 1.14%, changed from $118.44 before the earnings release to $119.79 the day after.
When is Gilead Sciences Inc expected to report next?
The next earning report is scheduled for 09 de fev. de 2026.
What are the forecasts for Gilead Sciences Inc's next earnings report?
Based on 21
analistas, Gilead Sciences Inc is expected to report EPS of $1.89 and revenue of $7.81B for Q4 2025.